Thyroid Disease CARE Act of 2025

HR 6897, the Thyroid Disease CARE Act of 2025, directs the U.S. Department of Health and Human Services to fund research and public awareness efforts focused on thyroid disease. It authorizes $30 million annually (2026-2030) to study disparities in diagnosis, treatment, and outcomes - particularly for women and underserved groups like racial minorities, people with disabilities, and those with limited insurance - while developing new diagnostic tools and treatments. The bill also allocates $3 million yearly for a public campaign to educate patients about symptoms, treatment options, and screening, especially during pregnancy, and to train healthcare providers on equitable care. This legislation affects patients with thyroid conditions (including nodules and cancer), healthcare systems, and providers, without altering insurance coverage or creating new benefits.